2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-40352A
    Tofacitinib impurity 6
    Tofacitinib impurity 6 is an impurity of Tofacitinib (HY-40354).
    Tofacitinib impurity 6
  • HY-75577
    4-Amino-3-methoxybenzoic acid
    		99.50%
    4-Amino-3-methoxybenzoic acid is a drug intermediate that can be used to construct benzothiazole compounds with anti-breast cancer activity.
    4-Amino-3-methoxybenzoic acid
  • HY-116284
    Methyl β-D-glucopyranoside
    		99.91%
    Methyl β-D-glucopyranoside (Methyl β-D-glucoside) is a model glycosyl acceptor for enzymatic glycosylation reactions. Methyl β-D-glucopyranoside participates in glycoside synthesis and can react with acyl donors such as caffeic acid esters under the catalysis of specific enzymes (such as Lipozyme TL IM) to achieve acylation modification. Methyl β-D-glucopyranoside can generate biologically active derivatives (such as 6-O-caffeoyl glucoside). Methyl β-D-glucopyranoside can be used in organic synthesis and biocatalysis research, especially the efficient enzymatic preparation of medicinal glycosides (such as Robustaside B (HY-N2720), 6-O-caffeoyl salidroside).
    Methyl β-D-glucopyranoside
  • HY-W013751
    Fmoc-Gly-Val-OH
    		99.82%
    Fmoc-Gly-Val-OH (N-Fmoc-glycyl-L-valine) is a glycyl valine derivative, can be used for the synthesis of drugs or other compounds.
    Fmoc-Gly-Val-OH
  • HY-W001095
    N-Methoxy-N-methylacetamide
    		99.99%
    N-Methoxy-N-methylacetamide can efficiently acetylate polycarbonyl compounds. As an important intermediate, N-Methoxy-N-methylacetamide can be used for the synthesis of other active compounds.
    N-Methoxy-N-methylacetamide
  • HY-69055
    7-Bromoisoquinoline
    		99.98%
    7-Bromoisoquinoline is a drug intermediate that can be used for the synthesis of Cortistatin A.
    7-Bromoisoquinoline
  • HY-160804
    Desmethyl nevanimibe
    		98.40%
    Desmethyl nevanimibe (Compound 5) is the demethyl precursor of the sterol O-acyltransferase 1 (SOAT1) inhibitor Nevanimibe (PD-132301).
    Desmethyl nevanimibe
  • HY-W010255R
    Phenylglyoxylic acid (Standard)
    Phenylglyoxylic acid (Standard) (Benzoylformic acid (Standard)) is the analytical standard of Phenylglyoxylic acid (HY-W010255). This product is intended for research and analytical applications. Phenylglyoxylic acid (Benzoylformic acid) is a metabolite of ethylbenzene and styrene (EB/S) and can be used as a biomarker of exposure to EB/S in human. Phenylglyoxylic acid can be used as drug intermediate for synthesis of antineoplastic compounds.
    Phenylglyoxylic acid (Standard)
  • HY-B1079
    Suxibuzone
    		99.74%
    Suxibuzone is a compound used for the study of joint and muscle pain, and it is a prodrug of the non-steroidal anti-inflammatory drug Phenylbutazone.
    Suxibuzone
  • HY-W007614
    3-Fluoro-4-methoxybenzaldehyde
    		99.92%
    3-Fluoro-4-methoxybenzaldehyde (3-Fluoro-para-anisaldehyde) is a drug intermediate that can be used to synthesize the fluorinated derivative of Combretastatin A-4 (HY-N2146), which has anti-cancer activity.
    3-Fluoro-4-methoxybenzaldehyde
  • HY-W016620
    3-Acetylphenyl acetate
    		99.85%
    3-Acetylphenyl acetate (Tetramethyl thiol alcynic acid) can be used as pharmaceutical intermediates.
    3-Acetylphenyl acetate
  • HY-P5025
    Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle)
    		99.16%
    Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle) (Azido-c(RGDyK)) is a polypeptide composed of arginine, glycine, aspartic acid, and tyrosine that can be used for Synthesis of [18F]FPyKYNE-c(RGDyK).
    Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle)
  • HY-W014217
    7-Aminodeacetoxycephalosporanic acid
    		98.0%
    7-Aminodeacetoxycephalosporanic acid (7-ADCA) is a key intermediate in the synthesis of cephalosporins.
    7-Aminodeacetoxycephalosporanic acid
  • HY-W001851
    1-Benzylpyrrole-2,5-dione
    		99.88%
    1-Benzylpyrrole-2,5-dione (N-Benzylmaleimide) is a heterocyclic compound containing a maleimide ring and a benzyl group. 1-Benzylpyrrole-2,5-dione can be used as a key reactant for the green chemical modification of cellulose nanocrystals (CNC).
    1-Benzylpyrrole-2,5-dione
  • HY-W008753
    Z-L-Val-OH
    		99.79%
    Z-L-Val-OH (N-Cbz-L-valine) is an amino acid derivative and key intermediate in organic synthesis. Z-L-Val-OH can be used in the synthesis of anti-cytomegalovirus compounds and peptide inhibitors of human spleen plasminogen activator (SFP) and human leukocyte elastase-like protease (ELP) .
    Z-L-Val-OH
  • HY-W009948
    Vanillin acetate
    		99.94%
    Vanillin acetate is a phenol ester that can be synthesized from vanillin by treatment with acetic anhydride.
    Vanillin acetate
  • HY-W007518
    4-Bromo-3-fluorobenzaldehyde
    		99.89%
    4-Bromo-3-fluorobenzaldehyde is a drug intermediate that can be used for the synthesis of triaryl dimer antibacterial compounds.
    4-Bromo-3-fluorobenzaldehyde
  • HY-76558
    Ethyl 4-chloro-2-(methylthio)pyrimidine-5-carboxylate
    		99.44%
    Ethyl 4-chloro-2-(methylthio)pyrimidine-5-carboxylate is a drug intermediate. Ethyl 4-chloro-2-(methylthio)pyrimidine-5-carboxylate can be used to synthesize inhibitors of various kinases such as Cdk4, PDGF, FGF, EGF.
    Ethyl 4-chloro-2-(methylthio)pyrimidine-5-carboxylate
  • HY-78144
    4-Methylsalicylic acid
    		99.97%
    4-Methylsalicylic acid is a methyl derivative of Salicylic acid (HY-B0167). 4-Methylsalicylic acid derivatives inhibit the activity of alkaline phosphatases such as TNAP and IAP. 4-Methylsalicylic acid derivatives exhibit immunosuppressive activity.
    4-Methylsalicylic acid
  • HY-W004698
    (2-Methoxypyrimidin-5-yl)boronic acid
    		99.95%
    (2-Methoxypyrimidin-5-yl)boronic acid is a drug intermediate that can serve as a key reactant in the Suzuki-Miyaura coupling reaction, and is used for the synthesis of isoquinoline ketone derivatives with anti-tumor activity.
    (2-Methoxypyrimidin-5-yl)boronic acid